Skip to content

The Early Diagnosis and Warning Role of Erectile Dysfunction

The Early Diagnosis and Warning Role of Erectile Dysfunction:a Multi-institutional Clinical Study.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01249703
Enrollment
150000
Registered
2010-11-30
Start date
2008-01-31
Completion date
2020-01-31
Last updated
2010-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Dysfunction, Erectile Dysfunction

Brief summary

1. Find the early diagnostic markers of erectile dysfunction; 2. Study the warning role of ED in some diseases.

Interventions

None listed

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male and at least 18 years of age. 2. Provide signed informed consent. 3. Have a history of erectile dysfunction (ED: defined as a consistent change in the quality of erection that adversely affects the subject's satisfaction with sexual intercourse) . 4. Have a stable monogamous relationship with a female partner. To some subjects with poor sexual experience, re-evaluation would be conducted after a 4-weeks sex education. 5. Make at least four sexual intercourse attempts with the female sexual study partner during the 4-week therapeutic period without medication. 6. Agree not to use any other ED treatment for at least 4 weeks.

Exclusion criteria

1. severe diseases (such as congestive heart failure, arrhythmia, significant renal or hepatic dysfunction and anemia); 2. Had clinically noteworthy penile deformities, pelvic surgery or trauma of perineal region; 3. Had received long-term pharmacotherapy (including antioxidant agents, vitamins and traditional Chinese drugs). 4. An addiction problem (with a history of injection or administration of opium, poppy, heroin, hemp, morphine, cocaine, caffeine, ketamine and meperidine etc.)

Countries

China

Contacts

Primary ContactChunhua Deng, MD, PhD
dch0313@163.com(01186)20-87333300
Backup ContactYanping Huang, MD
hyppin@gmail.com(01186)20-87333300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026